ScienceDaily
Crossing the ring: New method enables C-H activation across saturated carbocycles
Chemists add another powerful tool to their 'molecular editing' toolkit for crafting pharmaceuticals and other valuable compounds.
Read More
ScienceDaily
New class of antibiotics to fight resistant bacteria
Health professionals are in urgent need of new antibiotics to tackle resistant bacteria. Researchers have now modified the chemical structure of naturally occurring peptides to develop antimicrobial molecules that bind to novel targets in the bacteria's metabolism.
Read More
ScienceDaily
Eye drops slow nearsightedness progression in kids: Clinical trial suggests low-dose atropine is effective myopia treatment
The results of a new clinical trial suggest that the first drug therapy to slow the progression of nearsightedness in kids could be on the horizon. The three-year study found that a daily drop in each eye of a low dose of atropine, a drug used to dilate pupils, was better than a placebo at limiting eyeglass prescription changes and inhibiting elongation of the eye in nearsighted children aged 6 to 10.
Read More
ScienceDaily
A new way to develop drugs without side effects
Have you ever wondered how drugs reach their targets and achieve their function within our bodies? If a drug molecule or a ligand is a message, an inbox is typically a receptor in the cell membrane. One such receptor involved in relaying molecular signals is a G protein-coupled receptor (GPCR). About one-third of existing drugs work by controlling the activation of this protein. Researchers now reveal a new way of activating GPCR by triggering shape changes in the intracellular region of the receptor. This new process can help researchers design drugs with fewer or no side effects.
Read More
The Daily Beast
American Man Arrested After Fatal Attack at Fairytale Castle in Germany
The suspect allegedly tried to sexually assault two young women, authorities said.
Read More